Friday - April 19, 2024

Category Archives: Financial Market

Global Need, Major Deals, and Innovative Technology Send ASP Isotopes Shares 91% Higher Since July ($ASPI)

Investors wanting low-priced exposure in companies that are revolutionary to their sectors should waste no time learning about ASP Isotopes, Inc. (NasdaqCM: ASPI). More and more investors are beginning to heed that advice, contributing to ASPI shares surging by over … Continue reading →

Hepatitis C Virus Infection Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, PMDA Approvals | GeneCure, Biotron, Cocrystal Pharma, Genecure, iQur, Dongguan, TaiGen

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Hepatitis C Virus Infection therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action … Continue reading →

Immune Thrombocytopenic Purpura Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Sanofi, Takeda, Rigel Pharmaceuticals, Bristol-Myers Squibb

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 30+ key pharma and biotech companies are working on 25+ pipeline drugs in the Immune Thrombocytopenic Purpura therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), … Continue reading →

Waldenstroms Macroglobulinaemia Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Amgen, Abbvie, Roche, TransThera, BeiGene, Janssen, InnoCare

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 20+ key pharma and biotech companies are working on 22+ pipeline drugs in the Waldenstroms Macroglobulinaemia therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and … Continue reading →

Duchenne Muscular Dystrophy Market: Latest Study by DelveInsight Forecasts Remarkable Growth During the Forecast Period (2023-32) | Santhera, Sarepta, Italfarmaco, FibroGen, ENCell

Delveinsight Business Research LLP Duchenne Muscular Dystrophy Market size in the seven major markets was USD 745.4 Million in 2020, which is expected to grow by 2032. As per DelveInsight, the Duchenne Muscular Dystrophy Market is anticipated to evolve immensely … Continue reading →

Sporadic Inclusion Body Myositis (sIBM) Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) – Estimates DelveInsight | Novartis, Orphazyme, Dalazatide

Delveinsight Business Research LLP As per DelveInsight, the Sporadic Inclusion Body Myositis Market is anticipated to evolve immensely in the coming years owing to the rise in the number of prevalent cases of sIBM patients in the 7MM, the rise … Continue reading →